Modulating apoptosis: current applications and prospects for future drug development
Agents modulating apoptosis are of extraordinary promise for the treatment of several states of disease including cancer, AIDS, neurodegenerative and ischemic diseases. In this review a brief summary of cellular pathways relevant to programmed cell death first is given and potential therapeutic targ...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1999 May
|
| In: |
Current medicinal chemistry
Year: 1999, Volume: 6, Issue: 5, Pages: 399-414 |
| ISSN: | 1875-533X |
| Online Access: | Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pubmed/10101220
|
| Author Notes: | H.P. Deigner, R. Kinscherf |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1563365413 | ||
| 003 | DE-627 | ||
| 005 | 20230427122055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170911s1999 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1563365413 | ||
| 035 | |a (DE-576)493365419 | ||
| 035 | |a (DE-599)BSZ493365419 | ||
| 035 | |a (OCoLC)1340979015 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Deigner, Hans-Peter |d 1958- |e VerfasserIn |0 (DE-588)1012570606 |0 (DE-627)699716705 |0 (DE-576)345618505 |4 aut | |
| 245 | 1 | 0 | |a Modulating apoptosis |b current applications and prospects for future drug development |c H.P. Deigner, R. Kinscherf |
| 264 | 1 | |c 1999 May | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.09.2017 | ||
| 520 | |a Agents modulating apoptosis are of extraordinary promise for the treatment of several states of disease including cancer, AIDS, neurodegenerative and ischemic diseases. In this review a brief summary of cellular pathways relevant to programmed cell death first is given and potential therapeutic targets therein are emphasized. Current efforts in drug development are discussed from a mechanistic, biochemical point of view and pro- and anti-apoptotic strategies are related to the respective diseases. Therapeutic approaches addressed in this paper include the design and activity of novel low molecular weight agents (e.g. caspase inhibitors) as well as gene therapy (e.g. p53, adenovirus as vector in cancer treatment). In final sections, the latest findings in the field of apoptosis are highlighted and future applications are outlined. | ||
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Antigens, CD95 | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Ceramides | |
| 650 | 4 | |a Cysteine Proteinase Inhibitors | |
| 650 | 4 | |a Cytochrome c Group | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Mitochondria | |
| 650 | 4 | |a NF-kappa B | |
| 650 | 4 | |a Oxidative Stress | |
| 650 | 4 | |a Proto-Oncogene Proteins c-bcl-2 | |
| 650 | 4 | |a Receptors, Tumor Necrosis Factor | |
| 700 | 1 | |a Kinscherf, Ralf |e VerfasserIn |0 (DE-588)1084823748 |0 (DE-627)848747925 |0 (DE-576)169729516 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 1996 |g 6(1999), 5, Seite 399-414 |h Online-Ressource |w (DE-627)325051623 |w (DE-600)2034240-8 |w (DE-576)273880209 |x 1875-533X |7 nnas |a Modulating apoptosis current applications and prospects for future drug development |
| 773 | 1 | 8 | |g volume:6 |g year:1999 |g number:5 |g pages:399-414 |g extent:16 |a Modulating apoptosis current applications and prospects for future drug development |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pubmed/10101220 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170911 | ||
| 993 | |a Article | ||
| 994 | |a 1999 | ||
| 998 | |g 1084823748 |a Kinscherf, Ralf |m 1084823748:Kinscherf, Ralf |d 50000 |d 53100 |e 50000PK1084823748 |e 53100PK1084823748 |k 0/50000/ |k 1/50000/53100/ |p 2 |y j | ||
| 998 | |g 1012570606 |a Deigner, Hans-Peter |m 1012570606:Deigner, Hans-Peter |d 160000 |d 160100 |e 160000PD1012570606 |e 160100PD1012570606 |k 0/160000/ |k 1/160000/160100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1563365413 |e 2979975958 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1563365413","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 11.09.2017"],"title":[{"title":"Modulating apoptosis","subtitle":"current applications and prospects for future drug development","title_sort":"Modulating apoptosis"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Deigner, Hans-Peter","given":"Hans-Peter","family":"Deigner"},{"given":"Ralf","family":"Kinscherf","role":"aut","display":"Kinscherf, Ralf","roleDisplay":"VerfasserIn"}],"relHost":[{"title":[{"subtitle":"the leading journal for timely in-depth reviews in medicinal chemistry","title":"Current medicinal chemistry","title_sort":"Current medicinal chemistry"}],"language":["eng"],"recId":"325051623","note":["Frühere Jahrgänge online nicht mehr verfügbar","Gesehen am 23.06.25"],"disp":"Modulating apoptosis current applications and prospects for future drug developmentCurrent medicinal chemistry","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"16","text":"6(1999), 5, Seite 399-414","volume":"6","issue":"5","pages":"399-414","year":"1999"},"pubHistory":["Nachgewiesen 3.1996 -"],"id":{"issn":["1875-533X"],"zdb":["2034240-8"],"eki":["325051623"]},"origin":[{"dateIssuedKey":"1996","publisher":"Bentham Science Publ.","dateIssuedDisp":"1996-","publisherPlace":"Hilversum [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"16 S."}],"id":{"eki":["1563365413"]},"origin":[{"dateIssuedDisp":"1999 May","dateIssuedKey":"1999"}],"name":{"displayForm":["H.P. Deigner, R. Kinscherf"]}} | ||
| SRT | |a DEIGNERHANMODULATING1999 | ||